Novel algorithm predicts drug combinations to treat drug resistant fungal infections

July 14, 2016

Scientists have created an algorithm that can identify drug combinations to treat fungal infections that have become resistant to current drug treatments. This new study, published in PLOS Computational Biology, represents a strategy for treating complex diseases and finding new uses for existing drugs.

Fungal infections are one of the leading causes of hospital-acquired infections and are therefore associated with high mortality rates due to growing populations of patients with . Unfortunately, drug resistance is common for fungus-causing diseases and so there is an urgent need to develop new therapies to overcome this.

Drug combinations have been widely used in biomedical research and medical practices for treating various diseases. In particular, synergistic drug combinations are an effective strategy to overcome drug resistance, increase treatment efficacy and decrease drug dosage to avoid toxicity. Traditionally, effective drug combinations have been identified through experimentally screening all possible combinations of a pre-defined set of drugs - which is expensive, time consuming and labour intensive.

The authors, led by Professor Yan Guiying from the Chinese Academy of Sciences, created a novel algorithm termed Network-based Laplacian regularized Least Square Synergistic drug combination prediction (NLLSS), to predict potential synergistic drug combinations. It does this by integrating different kinds of information such as known synergistic drug combinations, drug-target interactions and drug chemical structures.

The study then uses NLLSS to predict antifungal synergistic drug combinations for the fungal pathogen Candida albicans. This pathogen causes candidiasis which develops into the fourth most common fungal blood stream infection among hospitalized patients in the United States - according to the Centers for Disease Control & Prevention. Using NLLSS, the scientists, led by Prof. Zhang Lixin from the Chinese Academy of Sciences, experimentally validated 7 out of 13 predicted antifungal synergistic drug combinations for Candida albicans - which could provide new treatments and work towards overcoming fungal for this pathogen.

This research shows that NLLSS is an efficient strategy to identify potential synergistic antifungal combinations, explore new indications of existing drugs, and provide useful insights into the underlying molecular mechanisms of synergistic .

Explore further: Drug combinations a good approach for infectious fungus, research shows

More information: PLOS Computational Biology, dx.plos.org/10.1371/journal.pcbi.1004975

Related Stories

Drug combinations a good approach for infectious fungus, research shows

February 6, 2015
Researchers at the University of Toronto have discovered that Candida albicans—a leading cause of potentially fatal hospital-acquired infections—rarely develops resistance to combination drug therapy and, when it becomes ...

Massive screen of drug combinations may find treatment for resistant, BRAF-mutant melanoma

October 26, 2015
A team of Massachusetts General Hospital (MGH) investigators has discovered a new combination of drugs that may be effective against one of the deadliest cancers, malignant melanoma. The combination - pairing a drug targeted ...

Researchers create genetic blueprint of cunning tuberculosis bacteria

June 6, 2016
The rise in multi-drug resistant (MDR) and extremely drug resistant (XDR) strains of Mycobacterium tuberculosis (MTB) is becoming a major cause of global health concern for treating tuberculosis, which affects a third of ...

'Imperfect drug penetration' speeds pathogens' resistance, study finds

May 18, 2015
Prescribing patients two or more drugs that do not reach the same parts of the body could accelerate a pathogen's resistance to all of the drugs being used in treatment, according to a new study published today in the Proceedings ...

New drug combinations could significantly improve tuberculosis treatment

March 28, 2016
Researchers from UCLA and Shanghai Jiao Tong University have made an important step toward a substantially faster and more effective treatment for tuberculosis, which infects some 10 million people and causes 1.5 million ...

Recommended for you

Pneumonia vaccine under development provides 'most comprehensive coverage' to date, alleviates antimicrobial concerns

October 20, 2017
In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million.

Newly discovered viral marker could help predict flu severity in infected patients

October 20, 2017
Flu viruses contain defective genetic material that may activate the immune system in infected patients, and new research published in PLOS Pathogens suggests that lower levels of these molecules could increase flu severity.

H7N9 influenza is both lethal and transmissible in animal model for flu

October 19, 2017
In 2013, an influenza virus that had never before been detected began circulating among poultry in China. It caused several waves of human infection and in late 2016, the number of people to become sick from the H7N9 virus ...

Flu simulations suggest pandemics more likely in spring, early summer

October 19, 2017
New statistical simulations suggest that Northern Hemisphere flu pandemics are most likely to emerge in late spring or early summer at the tail end of the normal flu season, according to a new study published in PLOS Computational ...

New insights into herpes virus could inform vaccine development

October 18, 2017
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.